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Abstract 
Precise orchestration of actin polymer into filaments with distinct characteristics of 
stability, bundling and branching underpins cell migration. A key regulator of actin 
filament specialization is the tropomyosin family of actin-associating proteins. This 
multi-isoform family of proteins assemble into polymers that lie in the major groove of 
polymerized actin filaments, which in turn determine the association of molecules that 
control actin filament organization. This suggests that tropomyosins may be important 
regulators of actin function during physiological processes dependent on cell migration 
such as wound healing. We have therefore analysed the requirement for tropomyosin 
isoform expression in a mouse model of cutaneous wound healing. We find that mice, in 
which the 9D exon from the TPM3/γTm tropomyosin gene is deleted (γ9D -/-), exhibit a 
more rapid wound healing response 7 days after wounding compared to Wildtype (WT) 
mice. Accelerated wound healing was not associated with increased cell proliferation, 
matrix remodelling or epidermal abnormalities but with increased cell migration. Rac 
GTPase activity and paxillin phosphorylation are elevated in cells from γ9D -/- mice, 
suggesting activation of paxillin/Rac signalling. Collectively, our data reveal that 
tropomyosin isoform expression plays an important role in temporal regulation of cell 
migration during wound healing. 
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Introduction 
Wound healing is an orchestrated multi-tissue response, requiring cell migration (Singer 
and Clark, 1999). Different phases of wound healing follow an orderly timetable, with 
each phase preparing the wound for subsequent steps necessary to restore the tissue 
barrier. An important step in this timetable is the migration of keratinocytes and 
fibroblasts into the wound bed. Approximately 7 days after wounding, fibroblasts move 
into the wounded area along collagen fibres and recruitment of these cells to the wound 
subsequently regulates matrix reorganization and wound contraction (Clark et al., 2007; 
Gurtner et al., 2008; Tomasek et al., 2002). Central to the ability of fibroblasts and 
keratinocytes to move into the wound area is a dynamic and responsive actin 
cytoskeleton. Emphasizing the requirement for an orderly execution of the wound healing 
timetable, manipulations that increase the rate of dermal fibroblast infiltration 
correspondingly cause more rapid wound closure (Reynolds et al., 2005). Thus molecules 
which regulate actin filament dynamics and thereby change the rate of cell migration can 
alter the rate of wound healing (Castilho et al., 2010; Cowin et al., 2007; Kopecki and 
Cowin, 2008; Liu et al., 2009; Tscharntke et al., 2007; Witke et al., 1995). The 
tropomyosin family of actin-associating proteins display tissue-specific and time-
dependent expression and their association with actin filaments imparts isoform-specific 
regulation of the associated actin filament (Gunning et al., 2008). While there is 
mounting in vitro evidence that tropomyosins regulate cell migration (Lees et al., 2011a), 
the role of these proteins has not previously been examined during in vivo wound 
healing. 
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Tropomyosins assemble as polymers that lie in the major groove of polymerized actin 
filaments (Gunning et al., 2008). Tropomyosin association with actin filaments in turn 
determines the association of molecules that control actin filament turnover (Blanchoin et 
al., 2001; Bryce et al., 2003; Ishikawa et al., 1989). Thus the pattern of tropomyosin 
decoration of actin filaments defines the function of the associated filament (Gunning et 
al., 2008). Low-molecular weight non-muscle tropomyosin isoforms Tm5NM1 and 
Tm5NM2 are two splice forms from the TPM3/γTm gene containing exon 9D from this 
gene sequence. We have previously shown that elevated Tm5NM1 expression inhibits 
cell migration in vitro and inversely correlates with the rate of elongated, adhesion-
dependent cell migration in 3-dimensional collagen gels (Bach et al., 2009; Lees et al., 
2011b). Significantly, elongated, adhesion-dependent migration is used by fibroblasts and 
keratinocytes during wound healing. 
 
The elongated form of cell migration exhibited by fibroblasts relies on activation of the 
small GTPase Rac (Sanz-Moreno et al., 2008), which stimulates formation of 
lamellipodia and small precursor adhesion complexes at the leading edge (Nobes and 
Hall, 1995). In vivo, conditional Rac1 deletion in epidermal keratinocytes (Castilho et al., 
2010; Tscharntke et al., 2007) and dermal fibroblasts (Liu et al., 2009) significantly 
impairs wound healing. Studies in vitro have revealed that Rac activity is required in 
fibroblasts for lamellipodial persistence and migration in scratch wound healing assays 
(Nobes and Hall, 1999). Our previous work showing that fibroblasts derived from mice 
lacking Tm5NM1/2 have increased Rac-dependent formation of precursor adhesions and 
strikingly increased persistence when migrating into a scratch wound in vitro (Bach et al., 
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2009) thus suggests that Rac activity may be increased in these mice, potentially leading 
to accelerated wound healing.  
 
Adhesion proteins such as paxillin that are phosphorylated by Src kinase are major 
regulators of Rac GTPase activity at the leading edge. Upon phosphorylation by Src, 
paxillin recruits Rac guanine nucleotide exchange factor DOCK180 to the leading edge 
by binding to the adaptor protein Crk, which is constitutively associated with DOCK180 
(Valles et al., 2004). DOCK180 in turn catalyzes Rac activation (Kiyokawa et al., 1998). 
Critical to this process is disassembly of mature focal adhesions at the base of the 
lamellipodium, which are associated with bundles of polymerized actin in the cell body. 
The disassembly of these sites precedes the formation of new Rac-dependent adhesions at 
the leading edge of the cell (Webb et al., 2003) and increased tension on the actin 
filament is suggested to reduce phosphorylation of paxillin at focal adhesion sites 
(Zaidel-Bar et al., 2007). Elevated Tm5NM1 expression inhibits Src activation (Lees et 
al., 2011b), stabilizes mature focal adhesions (Bach et al., 2009), increases myosin II 
recruitment and actin filament tension (Bryce et al., 2003) and is inversely correlated 
with phosphorylation of paxillin (Bach et al., 2009). Conversely genetic deletion of 
Tm5NM1 leads to increased Rac-dependent pre-cursor adhesion and lamellipodial 
formation (Bach et al., 2009).  
 
The levels of Tm5NM1/2 in different organs in the body range from low levels in the 
heart and muscle to many-fold increased levels in organs such brain, kidney and spleen 
(Schevzov et al., 2011). The function of these isoforms in the skin and how changes in 
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their expression might regulate the wound healing response requires further investigation. 
We therefore sought to understand the role of tropomyosin in the process of full thickness 
skin wound healing in Tm5NM1/2 homozygous knockout mice and Tm5NM1 
overexpressing transgenic mice. We show that wound healing is accelerated in 
Tm5NM1/2 -/- mice and that this may be due to effects on a paxillin/Rac migration 
signalling axis.  
 
7 
 
Results 
Wound healing is accelerated in Tm5NM1/2 knockout mice.  
We investigated the role of tropomyosins in regulating actin filament function during cell 
migration in vivo using a mouse model in which both copies of the TPM3/γTm gene exon 
9D are deleted (γ9D -/-), resulting in the loss of two tropomyosin isoforms, Tm5NM1 and 
Tm5NM2 (Fig 1a) (Fath et al., 2010). Measurement of cutaneous wound healing 
response revealed that at 7 days after wounding, Tm5NM1/2 -/- mice exhibited 
significantly shorter wound lengths than similarly treated WT control mice (Fig 1b, c). 
The acceleration in wound healing was restricted to the 7 day time point as at all other 
time points analysed (3, 14 and 21 days) there was no significance difference in the 
distance between the epithelial layers at the wound edge (Fig 1c). Comparison of total 
wound area and wound gape confirmed that at day 7 the wound area and gape was 
significantly smaller in the Tm5NM1/2 -/- mice (Fig 1d, e, f). Collectively, these 
measurements reveal that wound healing is specifically increased at day 7 in the mice 
lacking Tm5NM1/2.  
 
We next examined whether Tm5NM1/2 depletion altered skin tissue organization. 
Histological examination revealed no obvious differences in the structure of the 
epidermis, dermis, panniculus muscle and adipose tissue (Fig 1b and Fig 2a). Moreover, 
analysis of the epidermal layer by E-cadherin staining similarly revealed comparable 
organization in Tm5NM1/2 -/- and WT mice (Fig 2a). To determine whether Tm5NM1/2 
depletion might alter the distribution of collagen fibres critical to the wound healing 
response, we used picrosirius red (PSR) staining to measure collagen fibre distribution 
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(Fig 2b). This revealed no difference in collagen fibre distribution between WT and 
Tm5NM1/2 -/- mice, either in unwounded (UW) skin or after wounding (Fig 2b, c). Since 
cell proliferation plays a critical role in the wound healing response, we investigated 
whether increased proliferation could explain the accelerated wound healing in 
Tm5NM1/2 -/- mice. PCNA staining in the wound dermal region revealed no significant 
difference in the numbers of proliferating cells in WT and Tm5NM1/2 -/- mice (Fig 2d). 
Similarly, quantification of proliferating epidermal cells at day 3 after wounding revealed 
no significant differences. Using a collagen gel contraction assay we confirmed that 
increased wound healing is not due to increased contractility as the Tm5NM1/2 -/- MEFs 
did not display altered gel contraction (Figure 2e). Furthermore, there was no significant 
difference in the gape measured between the edges of the panniculus carnosus on either 
side of the wound at any time point regardless of genotype (Figure 2f). Collectively these 
analyses suggest that accelerated wound healing in the Tm5NM1/2 -/- mice is not due to 
altered structure of skin tissue, changes in cell proliferation or increased contractility. 
 
As fibroblasts and keratinocytes are the two major motile cell populations that mediate 
wound closure in the skin we determined whether these cells express Tm5NM1/2. Non-
specific antibody cross-reaction prevented analysis of Tm5NM1/2 by 
immunohistochemistry in tissue sections. Expression was therefore instead analysed in 
lysates extracted from isolated populations of primary fibroblasts and keratinocytes. This 
confirmed that both of these important motile cell types express endogenous Tm5NM1/2, 
at approximately equal levels (Fig 3a, b). We next analysed endogenous Tm5NM1/2 
expression in protein extracts of skin tissue at different time points after wounding in WT 
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mice. This revealed a striking up-regulation of Tm5NM1/2 expression in response to 
wounding (Fig 3c, d). Tm5NM1 levels were significantly increased at day 3 after 
wounding and gradually decreased over time (Fig 3c, d) suggesting either increased 
expression in cells present in the wound or the migration of Tm5NM1/2 positive cells 
into the wound area. Thus, we next examined whether elevated Tm5NM1 expression 
alters wound healing by employing a transgenic mouse that expresses human Tm5NM1 
(+/WT). Expression of the exogenous human transgene was confirmed by probing with 
LC1 antibody that specifically binds human Tm5NM1/2 (Schevzov et al., 2005) (Fig 3e). 
Increased total Tm5NM1 expression was confirmed by analysis with anti-γ9D antibodies 
that bind both endogenous mouse and exogenous human protein (Figure 3f and g). 
Analysis of the wound healing response in the transgenic mice revealed no significant 
difference in the wound lengths at either day 3 or day 7 after wounding between the WT 
and the transgenic overexpressing mice (Fig 3h). Thus, exogenous Tm5NM1 expression 
does not appear to alter cutaneous wound healing. Notably, increased Tm5NM1 
expression observed at day 3 in the wild-type mice (Fig 3c, d) is also observed in the 
transgenic mice (Fig 3 i, j). 
 
Tm5NM1/2 deletion activates a paxillin/Rac signalling axis 
Our previous work has suggested that Tm5NM1 expression is inversely correlated with 
activation of Src kinase and its down-stream substrate paxillin (Bach et al., 2009; Lees et 
al., 2011b). Since the phosphorylation of paxillin by Src kinase stimulates cell migration 
(Zaidel-Bar et al., 2007), we analysed paxillin expression and phosphorylation in UW 
skin. There was a trend for increased paxillin expression in UW skin from knock-out 
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mice (Figure 4a) and total paxillin phosphorylation was significantly increased (Figure 
4a). Paxillin is reported to signal down-stream to induce the activation of Rac GTPase 
(Valles et al., 2004) and we have previously shown that embryonic fibroblasts from 
Tm5NM1/2 -/- mice exhibit increased Rac-dependent formation of focal complexes and 
lamellipodia (Bach et al., 2009). Therefore, we hypothesized that Rac activation may 
underlie the increased migration in cells lacking Tm5NM1/2. Analysis of total Rac 
protein levels revealed that Rac expression was significantly increased in Tm5NM1/2 -/- 
cells compared to WT cells (Fig 4b). We then quantified Rac activity via GST pull-down 
assays and observed that Rac activity was also significantly increased in Tm5NM1/2 -/- 
cells (Fig 4c). We next addressed whether the increase in Rac activity could be attributed 
specifically to deletion of the Tm5NM1 isoform, as our previous work has established 
that high levels of Tm5NM1 can suppress cell migration (Bach et al., 2009; Bryce et al., 
2003; Lees et al., 2011b). This was addressed by analysing Rac expression and activity in 
a cell line that was created to express high level exogenous Tm5NM1 (Bryce et al., 
2003). Importantly, both total Rac protein and Rac GTPase activity are significantly 
reduced in cells with high level levels of Tm5NM1 (Fig 4b,c).  
 
As Rac activity stimulates the formation of lamellipodia, we examined sub-cellular 
distribution of Tm5NM1 during lamellipodial extension. Tm5NM1/2 -/- mouse embryo 
fibroblasts were transfected with YFP-tagged Tm5NM1 and observed by time-lapse 
imaging. Fluorescently-tagged Tm5NM1 was incorporated into actin stress fibres that 
traverse the cell body (Fig 5a). At the leading edge, the lamellipodium extends beyond 
the ends of Tm5NM1-positive filaments and the newly extended membrane is free of 
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Tm5NM1-positive filaments (arrow heads, Fig 5a). Subsequently, Tm5NM1-positive 
filaments formed in the lamellipodium and along the edge of the protruded membrane 
(arrows, Fig 5a). Tm5NM1-positive filaments at the membrane edge and in the 
lamellipodium then were frequently observed to join together with Tm5NM1 positive 
filaments in the cell body (Supplementary movie 1). We have previously demonstrated 
increased lamellipodial formation in Tm5NM1/2-/- MEFs by scoring for the presence of 
paxillin-positive focal complexes (Bach et al., 2009). Importantly, we here show that 
exogenous Tm5NM1 expression reduces lamellipodia formation in the Tm5NM1/2-/- 
MEFs (Fig 5b and c). Rescue experiments with exogenous Tm5NM2 that also localizes 
to stress fibres in the Tm5NM1/2-/- MEFs (Fig 5b), similarly reduced lamellipodial 
formation (Fig 5c). Thus restoration of exon 9D-containing products can inhibit the 
increased lamellipodial formation that occurs in the absence of these isoforms. 
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Discussion  
Mounting research has pointed to an important role for tropomyosins in specialising actin 
filament function, to coordinate the morphologies and force that underpin cell migration 
(Lees et al., 2011a). In the present study, we have investigated the role of γ9D exon-
containing isoforms from the γTm/TPM3 tropomyosin gene. Our studies reveal a change 
in the timing of wound healing in the absence of these gene products. We further show in 
cultured cells that elevated Tm5NM1 isoform expression causes the opposite effects to 
those seen in Tm5NM1/2 -/- fibroblasts. Together with recent studies showing that the 
drosophila tropomyosin TM1 gene is required for drosophila oocyte border cell migration 
(Kim et al., 2011), it appears that tropomyosins indeed have a role during physiological 
cell migration.  
 
In Tm5NM1/2 -/- mice, wound healing was specifically increased 7 days after wounding, 
while at later time points there was no difference in the wound size between the WT and 
knockout mice. Similarly, heterozygous deletion of FliI, homozygous deletion of 
glycogen synthase kinase-3 (GSK-3) and targeted homozygous deletion of the α3 
integrin subunit in the basal layer of the epidermis, all lead to smaller wound areas ~ 7 
days after wounding (Cowin et al., 2007; Kapoor et al., 2008; Margadant et al., 2008). 
While each of these genetic approaches promoted increased migration responses in 
isolated skin cells, they differ in the effects on proliferation and collagen deposition in the 
wound bed. Our results suggest that there is no change in proliferation, collagen 
composition or contractility in the Tm5NM1/2 -/- mice. Notably, while the effects of 
GSK-3 deletion persisted throughout the time course of wound healing (Kapoor et al,. 
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2008), similar to our findings, FliI effected the extent of wound healing at 7 days but by 
day 14 there was no difference between the controls and mice with genetically altered 
FliI expression (Cowin et al., 2007). Given the temporal separation of different phases of 
wound healing, our findings and the earlier data with FliI suggest that actin regulators 
may play a specific role during the migration phase that occurs at around 7 days after 
wounding.  
 
We have previously shown that re-expression of exogenous Tm5NM1 reduces the 
migration speed of Tm5NM1/2 -/- mouse embryo fibroblasts (Bach et al., 2009). 
Together with the observation that Tm5NM1/2 -/- mice exhibit more rapid wound 
healing, we thus hypothesized that transgenic overexpression of Tm5NM1 might cause 
delayed wound healing. However, there was no significant difference in wound healing 
between WT and transgenic mice expressing the human Tm5NM1 gene. We note that the 
inhibition of cell migration by Tm5NM1 requires high level exogenous Tm5NM1 
expression (Bach et al., 2009; Bryce et al., 2003). Potentially therefore the levels of 
Tm5NM1 expression in the transgenic mice were not sufficient to inhibit migration in the 
wound bed. However, we observed no correlation between the levels of exogenous 
Tm5NM1 expression and wound size (data not shown). Thus we suggest that it may be 
more likely, since endogenous Tm5NM1/2 is up-regulated following wounding, that 
there is a threshold effect of Tm5NM1 on wound healing such that the increase in total 
Tm5NM1 levels in the transgenic mice has no additional effect above that seen with 
endogenous Tm5NM1/2. Birth of γ9D -/- mice at less than expected Mendelian frequency 
(Hook et al., 2011) suggests that these forms are required for efficient embryogenesis. 
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Given the extensive migration events that occur during embryogenesis, potentially 
Tm5NM1/2 is required for specific migration events during embryogenesis, such as have 
been reported in drosophila embryos (Kim et al., 2011). 
 
Previous work has established that Rac is a major regulator of the rate of wound healing. 
Mice expressing dominant negative Rac in the skin keratinocytes show delayed wound 
healing (Tscharntke et al., 2007) and conditional deletion of Rac from either epithelial 
cells or fibroblasts resulted in significantly delayed wound healing (Castilho et al., 2010; 
Liu et al., 2009). Thus it is significant that both Rac protein and activity are significantly 
increased in Tm5NM1/2 -/- mouse embryo fibroblasts. Moreover, we show that in cells 
with elevated levels of Tm5NM1 expression Rac activity and protein expression is, 
conversely, significantly reduced. Given that Tm5NM1/2 is up-regulated subsequent to 
wound healing, we suggest that this may be part of a mechanism to regulate Rac 
activation and thus ensure that cell migration occurs in a timely fashion. Since Src 
phosphorylation of paxillin subsequently leads to Rac activation, increased expression of 
phosphorylated paxillin in Tm5NM1/2 -/- mice suggests hyper-activation of a 
paxillin/Rac signalling axis in the wounds of these mice. The spatial and temporal 
distribution of Tm5NM1 during lamellipodial extension suggests that the formation of 
Tm5NM1-decorated actin filaments correlates with local down-regulation of Rac activity. 
Moreover, extension of lamellipodia and formation of paxillin-positive focal complexes 
are Rac-dependent events and we show that exogenous expression of either Tm5NM1 or 
Tm5NM2 can suppress focal complex/lamellipodial formation in the Tm5NM1/2-/- 
MEFs. Our observation that Rac activity is inversely correlated with the expression of 
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Tm5NM1 suggests that Tm5NM1 may play a direct role in determining localized Rac 
activation. 
 
An important question raised by our study is how an actin associating molecule such as 
Tm5NM1 might regulate Rac expression and activity. It was recently demonstrated that 
depletion of the αTM/TPM1 gene products promotes Smurf1-mediated degradation of 
RhoA GTPase (Wong et al., 2011). In contrast, depleting βTM/TPM2 gene products had 
no effect on RhoA GTPase protein levels. Moreover, exogenous expression of isoform 
Tm2 from the αTM/TPM1 gene competed with Smurf1 for binding to RhoA, leading to 
RhoA protein stabilization. It is possible that Tm5NM1/2 may similarly regulate Rac 
GTPase protein expression. Alternatively, increased levels of phosphorylated paxillin and 
Rac GTPase activity in the Tm5NM1/2 -/- mouse embryo fibroblasts may represent a 
change in the mechanotransduction of these cells. Paxillin at focal adhesions is reported 
to undergo de-phosphorylation in response to increased tension through the associated 
actin filament (Zaidel-Bar et al., 2007). Since Tm5NM1 concentrates at the distal ends of 
stress fibres associated with focal adhesions (Tojkander et al., 2011) it localizes to the 
right location to have an effect on tension-dependent dephosphorylation of paxillin. Thus, 
when Tm5NM1 is present it may mediate tension-dependent dephosphorylation of 
paxillin, leading to locally decreased Rac GTPase activation. Conversely, in the absence 
of Tm5NM1 this control is lost leading to increased paxillin phosphorylation and 
increased Rac GTPase activity. 
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Materials and Methods  
Cell culture, antibodies and expression constructs 
Tm5NM1/2 homozygous null (-/-) and wild-type mouse embryo fibroblasts (MEF) and 
B35 rat neuroblastoma cells over-expressing exogenous human Tm5NM1 and conditions 
for transfection have been previously described (Bach et al., 2009). Keratinocytes 
extracted from the tail skin of WT mice have been described previously (Samuel et al., 
2011). Primary antibodies include: E-cadherin (1:250, Abcam, Cambridge, UK); 
proliferating cell nuclear antigen (PCNA) (1:200, Santa Cruz, CA), sheep anti-γ9D 
(1:500) (Schevzov et al., 2011) recognising Tm5NM1/2; mouse anti-human Tm5NM1/2 
(1:200) (LC1 clone); paxillin (1:500, BD bioscience, Franklin Lakes, NJ); phosphorylated 
paxillin (1:500, Invitrogen, Carlsbad, CA); anti-Rac (1:500, Cell Biolabs, San Diego, 
CA), HSP70 and HSP90 (Sigma, St Louis, MO); and GAPDH (Invitrogen, Carlsbad, 
CA). HRP-conjugated secondary antibodies for western blot were from Jackson 
Laboratories (Bar Harbor, ME), fluorescently tagged secondary antibodies for 
immunofluorescence from Invitrogen (Carlsbad, CA) and biotinylated horse anti-mouse 
IgG for immunohistochemistry from Vector Laboratories (Burlingame, CA).  
 
Cutaneous wound healing 
Mouse experiments were approved and performed in accordance with the Adelaide 
Women’s and Children’s Hospital Animal Care and Ethics Committee guidelines or the 
Australian National University Animal Ethics Committee following the Australian Code 
of Practice for the Care and the Use of Animals for Scientific Purposes. Tm5NM1/2 
deficient homozygous null mice (γ9D -/-) and transgenic animals expressing exogenous 
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human Tm5NM1 have been previously described (Schevzov et al., 2008; Vlahovich et 
al., 2009; Bryce et al., 2003), except that in the present study the Tm5NM1 transgene 
was transferred to the C57BL/6JArc mouse strain using speed congenic breeding. Both 
the Tm5NM1/2 null and Tm5NM1 transgenic mice were bred onto the C57BL/6JArc 
background for >10 generations. Two full-thickness 1 cm incisions were created on the 
dorsal skin of female, age matched (12-14 week) mice using the protocol previously 
described (Kopecki et al., 2007). Wound gape representing the average distance between 
opposing edges of the wound and wound area representing the total area visibly wounded 
were analysed with Image-Pro Plus 5.1 (Media Cybernetics Inc, Bethesda, MD). Wound 
length and panniculus gape were quantified by two separate, blinded investigators by 
measuring distance along the wound contour between the epithelium and between 
panniculus edges on either side of the wound from haematoxylin–eosin (H&E) stained 
4μm sections.  
 
Histology and immunohistochemistry  
Tissue sections were blocked (PBS/1% donkey serum/1% fatty acid free BSA for E-
cadherin; PBS/3% normal horse serum for PCNA) then incubated with primary and 
secondary antibodies in the same blocking buffer. PCNA-stained sections were developed 
using Vectastain ABC Kit followed by DAB kit (Vector Laboratories, Burlingame, CA) 
then dehydrated and mounted. Sections for immunofluorescence were mounted with 
Prolong gold containing DAPI (Invitrogen, Carlsbad, CA). Fluorescently stained sections 
were imaged under an Olympus IX81 inverted microscope, with a 20X Air objective, 
NA0.45, using an ORCA ERG cooled CCD camera (Hamamatsu/SDR Clinical 
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Technology, Hamamatsu City, Japan) and bright-field imaging of tissue sections was 
performed using an Aperio Scanscope with a 20 Air objective (Aperio, Vista, CA, USA). 
Picrosirius Red (PSR) staining of paraffin embedded mice tissue sections (5µm) was 
performed by the ICPMR, Westmead hospital and sections imaged using a Leica DC 500 
microscope with simplified polarized microscopy capability. Collagen fibre analyses 
were performed using Metamorph V7.0 colour separate function. Using only the hue 
component and a histogram of hue frequency from the resolved 8-bit images containing 
256 colours, hue definitions representing different collagen fibre thickness were 
quantified accordingly: red 2-9 and 230-256 (thickest fibres), orange 10-38 (thick fibres), 
yellow 39-51 (thin fibres), green 52-128 (thinnest fibres) (Rich and Whittaker, 2005). 
Dermal proliferation was scored by counting PCNA positive nuclei in a defined area of 
the dermal bed, in four fields of view from three independent mice. Epidermal 
proliferation was scored by counting the percentage of PCNA positive nuclei touching 
the basement membrane, within 1mm from the edge of the migrating tongue, in three 
independent mice for each treatment condition. Image analysis was performed using 
Metamorph V7.0 (Leica, Solms, Germany) and final micrograph images were prepared 
using Photoshop C2S (Adobe, San Jose, CA).  
 
Protein extraction and immunoblotting  
Wound tissue samples were diced with surgical scissors, then lysed on ice using vigorous 
dissociation through a 19 gauge needle in 0.1% RIPA-SDS buffer (50mM Tris [pH7.4], 
150mM NaCl, 5mM EDTA, 1% Nonidet P-40, 1% Na. Deoxycholate, 0.1% SDS freshly 
supplemented with 1 mM phenylmethylsulfonyl fluoride, 0.01 mg/ml aprotinin, 0.01 
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mg/ml leupeptin, and 1 mM Na3VO4). Cultured cells were lysed on ice in PTY buffer 
containing protease inhibitors (Cowell et al., 2006). Protein concentrations were 
determined using the BCA Protein Assay Kit (Pierce Biotechnology, Rockford, IL) and 
equalized prior to SDS-PAGE. Conditions of immunoblotting were performed as 
previously described (Cowell et al., 2006).  
 
Rac activity assay, lamellipodia analysis and collagen gel contraction 
Isolation and quantification of active Rac GTPase was performed by GST pull down as 
per the manufacturer’s instructions (Cell Biolabs, San Diego, CA). Results were 
quantified by densitometry. Paxillin immunofluorescence and assessment of focal 
complex positive lamellipodia were performed as previously described (Bach et al., 
2009). For collagen gel contraction 2.5 x 105 WT or Tm5NM1 -/- MEF were seeded in 
500µl of 2.5mg/ml rat tail collagen gels (BD bioscience) in 24 well plates. After 48 hours 
gels were released and contraction was quantified by measuring gel area after 3 days 
(Metamorph V7.0) 
 
Statistical analysis 
All error bars on histograms represent the standard error mean (S.E.M.). Statistical 
comparison of two means was performed by using Student’s t-test (GraphPad, La Jolla, 
CA) and comparison of more than two means was performed using one-way Analysis Of 
Variance with Tukey’s Multiple Comparison Test. 
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 Legends: 
Figure 1: Cutaneous wound healing is accelerated at day 7 in γ9D -/- mice. (a) 
Expression of Tm5NM1/2 in skin using antibodies that recognize the γ9D exon. HSP70 
probing is shown as loading control. (b) Haematoxylin and Eosin (H&E) stained 
transverse sections of full thickness wounds after 7 days (lines indicate the edges of 
wound area); scale bar = 500µm. Ep.-epidermis, Der.-dermis, Adi.-adipose tissue, Pan.-
panniculus. (c) Histogram shows average wound length (µm), at the indicated time 
periods (n=12 wounds). (d) Digital images of wounds at the indicated time periods; scale 
bar = 1mm. (e) Average wound area (mm2) and (f) average wound gape (mm), at the 
indicated time periods (n=12 wounds). *p<0.05, **p<0.01, N.S. = not significant.  
 
Figure 2: Skin tissue organization, proliferation and contractility. (a) H&E, E-
cadherin (magnification shown on the right) stained sections of epidermis; scale bars 
20µm and 10µm (magnified images). (b) PSR staining; scale bar 50µm. (c) Collagen 
fibre type distribution. (d) PCNA stained nuclei in dermis (upper panels) and epidermis 
(lower panels); scale bar 40µm. Histograms show the percentage of PCNA positive 
nuclei. White arrowhead, non-proliferating cell; Black arrowhead, proliferating cell. 
Dotted lines indicate the basement membrane. (e) Collagen contraction assay. Bright field 
image in left panels; scale bar = 200µm; gels on the right; scale bar = 2mm. Histogram 
shows average gel area 3 days after release. Results are the average from triplicate 
independent experiments. N.S. = not significant. (f) Histogram shows average panniculus 
gape length (mm), at the indicated time periods (n>6 wounds). 
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Figure 3: Tm5NM1/2 expression in skin. (a) Western blot of Tm5NM1/2 in 
Tm5NM1/2 -/-, WT MEFs and skin keratinocytes and (b) quantification relative to 
HSP70. (c) Tm5NM1/2 expression during wound healing in WT mice. (d) Tm5NM1/2 
expression, comparing levels at 3, 7 and 14 days after wounding to average levels in UW 
skin (n=3).  (e) Tm5NM1 transgene expression: LC1 antibody recognizes the exogenous 
human protein. (f) Endogenous and exogenous Tm5NM1/2 expression: anti-γ9D 
antibodies bind both endogenous mouse and transgenic human proteins. (g) Average total 
Tm5NM1/2 expression (n=4) and (h) wound lengths in transgenic mice (n=10 wounds). 
(i) western blot and (j) densitometric quantification of Tm5NM1/2 expression during 
wound healing in transgenic mice (n=3). HSP70 shown to indicate loading. N.S. = not 
significant. *p<0.05 
 
Figure 4: Tm5NM1 expression inversely correlates with paxillin phosphorylation 
and Rac activity. (a) Expression of paxillin (Pax) and phosphorylated paxillin (p-Pax) in 
unwounded (UW) mice (n=3). (b) Expression of Rac protein in WT and Tm5NM1/2 -/- 
MEF and B35 and B35.Tm5NM1 cells. (c) Rac GTPase pull-down assay. Immunoblots 
show positive (GTPγS) and negative (GDP) controls. Top panels show pull-downs from 
WT and Tm5NM1/2 -/- MEFs and bottom panels show pull-downs from B35 and 
B35.Tm5NM1 cells. All graphs show the average of three independent repeats and 
densitometry was performed using Image-J by comparing the ratio of gene of interest to 
housekeeping genes HSP70 or GAPDH. *p<0.05, ***p<0.001, N.S. = not significant. 
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Figure 5: Tm5NM1/2 regulation of lamellipodial protrusions. (a) Tm5NM1/2 -/- MEF 
expressing YFP-tagged Tm5NM1 scale, bar 20µm (i). The boxed region (i) is enlarged 
(ii), showing a montage of individual frames taken from time-lapse imaging of the YFP-
Tm5NM1 transfected cell. Arrow heads point to extending lamellipodium. Arrows point 
to the appearance of new Tm5NM1-positive filaments. Images taken at 5 minute 
intervals. Scale bar 5µm. (b) Tm5NM1/2-/- MEFs transfected with expression vectors for 
YFP, YFP.Tm5NM1 and YFP.Tm5NM2, fixed and stained with paxillin antibodies to 
detect adhesions. Arrow points to paxillin-positive focal complexes along the edge of 
lamellipodia. Scale bar 20µm. (c) Percentage of the indicated transfected cell populations 
displaying focal complex-positive lamellipodia. Data are the average from three separate 
experiments, n>30 cells scored per transfection. ***p<0.001. 
 
 
Supplementary Movie 1: Time-lapse movie of Tm5NM1/2 -/- mouse embryonic 
fibroblasts transfected with YFP.Tm5NM1. Cells were imaged with a 40x oil objective 
and images captured every 5 minutes for a total of 3 hours. 
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